Continue tracking protein intake even after active weight loss ends
Strategic fill-finish capacity was simultaneously secured through Novo Holdings' $16.5 billion acquisition of CDMO giant Catalent, through which Novo Nordisk gained three dedicated fill-finish manufacturing sites in Anagni, Italy, Brussels, Belgium, and Bloomington, Indiana, employing more than 3,000 people
Moreover, the specialized equipment required for pharmaceutical-grade SPPS represents a significant capital investment, and the expertise needed to operate and maintain these systems is concentrated in a relatively small number of contract manufacturing organizations globally
Read More Impossible Foods, Inc., the maker behind the popular meatless burger, Impossible Burger, is suing Motif Foodworks over claims of patent infringement